• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

radiopharmaceuticals

radiopharmaceutical
Pharma

Proposed nuclear rules threaten Novartis’ Pluvicto

Experts warn that a draft guide by nuclear authorities contains rigid assumptions that could add barriers to patient access to radiopharmaceuticals.
Angus Liu Oct 6, 2026 9:00am
radiopharmaceutical radiopharmaceuticals nuclear medicine radiopharma targeted alpha therapy

Radiopharmaceutical player NorthStar locks up $185M

Sep 30, 2026 9:00am
Curium

FDA approves first radioligand equivalent

Sep 15, 2026 8:38am
RayzeBio Indianapolis

BMS to build $173M radiopharmaceutical plant in Indiana

Aug 27, 2026 2:45pm
Graphic image of a red thumbs down against a blue background

ITM cancer drug spurned by FDA over manufacturing qualms

Aug 10, 2026 11:25am
MA
Favicon Fierce Biotech

Curium strikes up to $8B deal for radiopharma rival Lantheus

Aug 3, 2026 2:20pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings